Wealthfront Advisers
DNA icon

Wealthfront Advisers’s Ginkgo Bioworks DNA Stock Holding History

Wealthfront Advisers’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-423
Closed -$53K – 786
2022
Q3 		$53K Sell
423
-416
-50% -$52.1K ﹤0.01% 759
2022
Q2 		$80K Buy
+839
New +$80K ﹤0.01% 763